Hanseatic Management Services Inc Catalent, Inc. Transaction History

Hanseatic Management Services Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 30, 2021	SELL	$100.34 - $115.69 $18,462 - $21,286	-184 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$101.51 - $125.27 $101 - $125	1 Added 0.55%	184 $19,000
Q3 2020 Oct 29, 2020	BUY	$72.74 - $92.5 $13,311 - $16,927	183 New	183 $16,000
Q4 2017 Feb 14, 2018	SELL	$37.27 - $43.02 $3,018 - $3,484	-81 Closed	0 $0
Q3 2017 Nov 07, 2017	SELL	$33.75 - $41.67 $397,575 - $490,872	-11,780 Reduced 99.32%	81 $3,000
Q2 2017 Aug 11, 2017	BUY	N/A	11,861	11,861 $416,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Hanseatic Management Services Inc, based on Form 13F filings with the SEC.

Stay updated on Hanseatic Management Services Inc with notifications on news.